Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,242.00    -14.00 (-1.11%)
Bid:
1,238.00
Ask:
1,244.00
Spread: 6.00 (0.485%)
Market Cap: £569.16m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract Win

7 Nov 2016 07:00

RNS Number : 4324O
Cohort PLC
07 November 2016
 

Cohort plc

("Cohort")

 

Contract Win

 

SEA secures contracts to supply traffic enforcement systems to TfL

 

Cohort, the independent technology group, is pleased to announce that its subsidiary SEA has been awarded contracts by Transport for London (TfL) to further develop and provide ongoing support of its Digital Traffic Enforcement System (DTES) and to develop and support a Parking Enforcement Solution (PES) mobile application.

 

The combined orders are valued at approximately £7m and include 10 years' of support for both systems. SEA originally developed the DTES system on behalf of TfL. DTES entered into service in 2009 and SEA has provided support over the entire period.

 

Andy Thomis, Chief Executive of Cohort, said:

 

"I am delighted that SEA continues to be involved in this important TfL programme. The addition of the PES system to work with DTES is an exciting development.

 

"This adds further visibility to our order book, which underpins a significant proportion of revenues for Cohort's current financial year."

 

Ends

This announcement includes inside information.

 

For further information please contact:

 

 

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

 

Simon Walther, Finance Director

 

 

 

Investec Bank Plc

020 7597 5970

Keith Anderson / Daniel Adams

 

 

 

MHP Communications Limited

020 3128 8100

Reg Hoare / Jamie Ricketts / Ollie Hoare

 

 

 

NOTES TO EDITORS

Cohort plc

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through five market-facing subsidiary companies:

MASS - a specialist systems house with a focus on electronic warfare operational support, cyber defence and secure information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

MCL - an expert in sourcing, design and integration of surveillance and other electronic systems, as well as field support and training for the UK MOD and other government agencies. Based in Surrey, MCL has been part of the Group since July 2014;

SCS - a defence technical advisory business, providing a range of services, including independent technical evaluation of military aircraft safety, and design and delivery of large and small scale military training exercises. Owned by Cohort since flotation in March 2006;

SEA - an advanced systems and software business operating in the defence (naval systems, simulation, training and technology research), transport and offshore energy market sectors. Acquired by Cohort in October 2007.

EID - a Portugal based supplier of advanced electronics, communications and command and control products and systems for the global defence market, in which Cohort acquired a majority stake in June 2016.

Cohort was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 800 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Devon, Lincolnshire, Somerset, Surrey, Scotland and Portugal.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTAKQDBOBDDQDK
Date   Source Headline
16th Sep 20245:34 pmRNSHolding(s) in Company
2nd Sep 20245:08 pmRNSTotal Voting Rights
2nd Sep 202411:32 amRNSHolding(s) in Company
27th Aug 20245:54 pmRNSBlock listing six monthly return
21st Aug 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Aug 20243:48 pmRNSDirector/PDMR Shareholding
16th Aug 202412:10 pmRNSHolding(s) in Company
12th Aug 20244:22 pmRNSDirector/PDMR Shareholding
2nd Aug 20242:30 pmRNSDirector/PDMR Shareholding
1st Aug 202411:43 amRNSTotal Voting Rights
29th Jul 20249:45 amRNSDirector/PDMR Shareholding
23rd Jul 20245:04 pmRNSDirector/PDMR Shareholding
17th Jul 20247:01 amRNSContract win
17th Jul 20247:00 amRNSFinal Results
15th Jul 20247:00 amRNSContract Award
11th Jul 20247:00 amRNSNotice of Results
1st Jul 20249:33 amRNSTotal Voting Rights
5th Jun 202410:59 amRNSEBT Purchase of Shares
31st May 20243:17 pmRNSTotal Voting Rights
23rd May 20241:30 pmRNSEBT Purchase of Shares
23rd May 20247:00 amRNSFull Year Trading Update
20th May 20244:01 pmRNSEBT Purchase of Shares
14th May 20242:10 pmRNSEBT Purchase of Shares
7th May 20245:24 pmRNSEBT Purchase of Shares
3rd May 202411:44 amRNSDirector/PDMR Shareholding
1st May 20245:17 pmRNSDirector/PDMR Shareholding
1st May 20245:11 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSBlock Listing Application
30th Apr 20247:00 amRNSSite visit to SEA
15th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20242:19 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:19 pmRNSBlock Listing Six Monthly Return
2nd Apr 20243:17 pmRNSTotal Voting Rights
28th Mar 20242:06 pmRNSHolding(s) in Company
27th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSContract Win
19th Mar 20249:43 amRNSContract win
13th Mar 202410:49 amRNSDirector/PDMR Shareholding
1st Mar 20247:00 amRNSTotal Voting Rights
26th Feb 20244:28 pmRNSBlock listing six monthly return
16th Feb 202412:38 pmRNSDirector/PDMR Shareholding
1st Feb 202410:02 amRNSTotal Voting Rights
29th Jan 20247:00 amRNSContract Win
17th Jan 20243:25 pmRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSInterim Report 2023
2nd Jan 202412:05 pmRNSTotal Voting Rights
22nd Dec 202312:07 pmRNSHolding(s) in Company
13th Dec 20237:01 amRNSDirectorate Change
13th Dec 20237:00 amRNSHalf Year Results
7th Dec 20237:00 amRNSEquity Development Presentation on 13 December

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.